You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞普生物(300119.SZ)擬定增募資不超13.36億元 用於中岸生物改擴建項目等
格隆匯 03-15 21:37

格隆匯3月15日丨瑞普生物(300119.SZ)發佈2021年度向特定對象發行股票預案,本次向特定對象發行股票的數量不超過發行前股本總額的30%,即不超過1.21億股(含本數),發行對象不超過35名(含)。

擬募集資金總額不超過13.36億元(含本數),扣除發行費用後的募集資金淨額擬投入國際標準獸藥製劑自動化工廠建設項目、天然植物提取產業基地建設項目、華南生物大規模懸浮培養車間建設項目、超大規模全懸浮連續流細胞培養高效製備動物疫苗技術項目、研發中心升級改造—生物製品研究院二期項目、中岸生物改擴建項目、補充流動資金及償還銀行貸款。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account